CERT icon

Certara

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 57.1%
Negative

Neutral
GlobeNewsWire
2 days ago
Certara to Participate in Upcoming Investor Conferences
RADNOR, Pa., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:
Certara to Participate in Upcoming Investor Conferences
Neutral
Seeking Alpha
3 days ago
Certara, Inc. (CERT) Q4 2025 Earnings Call Transcript
Certara, Inc. (CERT) Q4 2025 Earnings Call Transcript
Certara, Inc. (CERT) Q4 2025 Earnings Call Transcript
Negative
Zacks Investment Research
3 days ago
Certara, Inc. (CERT) Q4 Earnings Lag Estimates
Certara, Inc. (CERT) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.15 per share a year ago.
Certara, Inc. (CERT) Q4 Earnings Lag Estimates
Neutral
GlobeNewsWire
4 days ago
Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance
FY 2025 Revenue of $418.8M (9% growth) and Adj. EBITDA of $134.5M (10% growth) Fourth Quarter Revenue of $103.6M (3% growth) and Adj.
Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance
Positive
Seeking Alpha
12 days ago
The London Company Small Cap  Q4 2025 Performance And Trades
The London Company Small Cap portfolio increased 2.7% (2.5% net) during the quarter vs. a 2.2% increase in the Russell 2000 Index. Contributors to relative performance were White Mountains Insurance Group Ltd, Revolve Group Inc. and Haemonetics Corporation. Detractors from relative performance were NewMarket Corporation, Certara, Inc. and Gates Industrial Corporation plc.
The London Company Small Cap  Q4 2025 Performance And Trades
Positive
Benzinga
27 days ago
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter
Neutral
GlobeNewsWire
1 month ago
Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025
RADNOR, Pa., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the fourth quarter and full year of 2025 before market open on Thursday, February 26th, 2026.
Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025
Neutral
Seeking Alpha
1 month ago
Wasatch Core Growth Fund Q4 2025 Performance Review
Shift4 Payments' stock was down after a competitor reported disappointing results, raising concerns for the industry. While Trex Co. is facing some current challenges, we still view Trex as a high-quality business. Fabrinet is seeing increased demand as data centers upgrade their networks to faster and lower-latency communication standards capable of handling complex AI workloads.
Wasatch Core Growth Fund Q4 2025 Performance Review
Neutral
Seeking Alpha
1 month ago
Cerrado Gold Inc. (CERT:CA) Discusses Purported Unfavourable Opinion of Environmental Impact Assessment for Lagoa Salgada Project Transcript
Cerrado Gold Inc. (CERT:CA) Discusses Purported Unfavourable Opinion of Environmental Impact Assessment for Lagoa Salgada Project Transcript
Cerrado Gold Inc. (CERT:CA) Discusses Purported Unfavourable Opinion of Environmental Impact Assessment for Lagoa Salgada Project Transcript
Neutral
The Motley Fool
1 month ago
Certara Stock Fell 23% After Earnings and This Fund Bought Up $3 Million Anyway
Texas-based Kopion Asset Management added 327,064 Certara shares in the fourth quarter; the estimated transaction size is $3.37 million based on average prices for the quarter. The value of the Certara position rose by $645,681 over the quarter, reflecting both additional shares and price movement.
Certara Stock Fell 23% After Earnings and This Fund Bought Up $3 Million Anyway